Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Advanced Search

Search

You could also try: motionless (1), immobile (3), static (29)

Lung stereotactic ablative body radiotherapy (SABR) - patient information

Description: This factsheet explains what lung stereotactic ablative body radiotherapy (SABR) is and what to expect during treatment.
Url: /Media/UHS-website-2019/Patientinformation/Cancercare/Lung-stereotactic-ablative-body-radiotherapy-SABR-2091-PIL.pdf

UHS Our People Strategy 2022 - 2026

Description: OUR PEOPLE STRATEGY 2022 to 2026 CONTENTS 05 Foreword by Steve Harris – chief people officer 06 Our strategic framework 07 Always Improv
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Plans-and-strategies/UHS-Our-People-Strategy-2022-2026.pdf

Going home with a CADD pump - patient information

Description: This factsheet explains what to expect if you are going home with a CADD pump.
Url: /Media/UHS-website-2019/Patientinformation/Cancercare/Going-home-with-a-CADD-pump-3090-PIL.pdf

Docetaxel

Description: Chemotherapy Protocol LUNG CANCER – NON-SMALL CELL (NSCLC) DOCETAXEL (75) Regimen NSCLC – Docetaxel (75) Indication Second line therapy of stage IIIB or IV NSCLC WHO
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Docetaxelver12.pdf

Cisplatin and Pemetrexed

Description: Chemotherapy Protocol LUNG CANCER – NON-SMALL CELL (NSCLC) CISPLATIN-PEMETREXED Regimen NSCLC – Cisplatin-Pemetrexed Indication First line therapy of stage III or IV adenocarcinoma
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/CisplatinandPemetrexedver12.pdf

MesoCisPemVer1.3

Description: Chemotherapy Protocol MESOTHELIOMA CISPLATIN-PEMETREXED Regimen Mesothelioma – Cisplatin-Pem
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Mesothelioma/MesoCisPemVer1.3.pdf

Bleomycin-Cisplatin-Etoposide (3 day-Mod-BEP) Ver1.2

Description: Chemotherapy Protocol GERM CELL BLEOMYCIN-CISPLATIN-ETOPOSIDE (BEP 3 Day Modified) Regimen Germ Cell – Bleomycin-Cisplatin-Etoposide (3 day-Mod-BEP) Indica
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Germcell/Bleomycin-Cisplatin-Etoposide-3-day-Mod-BEP-Ver1.2.pdf

Bleomycin-Cisplatin-Etoposide (3 day BEP) Ver1.2

Description: Chemotherapy Protocol GERM CELL BLEOMYCIN-CISPLATIN-ETOPOSIDE (BEP 3 Day) Regimen Germ Cell – Bleomycin-Cisplatin-Etoposide (3 day BEP) Indication In patie
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Germcell/Bleomycin-Cisplatin-Etoposide-3-day-BEP-Ver1.2.pdf

Cisplatin-Gemcitabine Version 1.2

Description: Chemotherapy Protocol BILIARY TRACT CANCER CISPLATIN-GEMCITABINE Regimen Biliary Tract Cancer – Cisplatin-Gemcitabine Indication First line therapy of locally advanced / metastatic bi
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Hepatobiliary/Cisplatin-Gemcitabine-Version-12.pdf

Recovering well after an endometrial resection or ablation - patient information

Description: This factsheet explains what to expect after having an endometrial resection or ablation, and how you can help your body to
Url: /Media/UHS-website-2019/Patientinformation/Womenshealth/Recovering-well-after-an-endometrial-resection-or-ablation-3054-PIL.pdf

391 to 400 of 501

Previous … 38 39 40 41 42 … Next